Science
Swiss Study to Prospectively Assess Value of Multi-Omic, Functional Tumor Profiling – Precision Oncology News
The TuPro study will evaluate whether a comprehensive suite of routine and emerging tests can add value to treatment decision making and improve outcomes.
This article has been updated with the number of patients involved in the study and timeline details.
NEW YORK A group of researchers in Switzerland has set out to show the feasibility of incorporating a comprehensive suite of tumor profiling technologies into the treatment decision-making process for cancer patients and prove that such a multi-omics approach will add value over standard approaches and improve precision therapy decisions.
The researchers outlined the design and aims of the Tumor…
-
Business23 hours agoWhy this fantastic blue chip ASX 200 share could rise 20%
-
General22 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals
-
General15 hours agoPhotographers reveal iconic image of Gough Whitlam and Vincent Lingiari was posed on Wave Hill Walk-Off anniversary
-
General17 hours agoBuilding standards frozen under housing speed-up plan